Pharmacology

Action Mechanism of Action Reference
None Somatic cell supplemental therapy

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hematologic Neoplasms 4 D019337 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298190
FDA SRS ET4JC4S66E